A phenomenological model for the relative biological effectiveness in therapeutic proton beams.

To study the effects of a variable relative biological effectiveness (RBE) in inverse treatment planning for proton therapy, fast methods for three-dimensional RBE calculations are required. We therefore propose a simple phenomenological model for the RBE in therapeutic proton beams. It describes the RBE as a function of the dose, the linear energy transfer (LET) and tissue specific parameters. Published experimental results for the dependence of the parameters alpha and beta from the linear-quadratic model on the dose averaged LET were evaluated. Using a linear function for alpha(LET) in the relevant LET region below 30 keV per micrometre and a constant beta, a simple formula for the RBE could be derived. The new model was able to reproduce the basic dependences of RBE on dose and LET, and the RBE values agreed well with experimental results. The model was also applied to spread-out Bragg peaks (SOBP), where the main effects of a variable RBE are an increase of the RBE along the SOBP plateau, and a shift in depth of the distal falloff. The new method allows fast RBE estimations and has therefore potential applications in iterative treatment planning for proton therapy.

[1]  Nina Tilly.  Radiobiological investigations of proton and light ion therapy , 2002 .

[2]  H Paganetti,et al.  Nuclear interactions in proton therapy: dose and relative biological effect distributions originating from primary and secondary particles. , 2002, Physics in medicine and biology.

[3]  T Kanai,et al.  Irradiation of mixed beam and design of spread-out Bragg peak for heavy-ion radiotherapy. , 1997, Radiation research.

[4]  Uwe Oelfke,et al.  Analytical linear energy transfer calculations for proton therapy. , 2003, Medical physics.

[5]  R. Katz,et al.  Theory of RBE for heavy ion bombardment of dry enzymes and viruses. , 1967, Radiation research.

[6]  R. Dale,et al.  The assessment of RBE effects using the concept of biologically effective dose. , 1999, International journal of radiation oncology, biology, physics.

[7]  M Goitein,et al.  Radiobiological significance of beamline dependent proton energy distributions in a spread-out Bragg peak. , 2000, Medical physics.

[8]  J. Savage,et al.  Chromosome aberrations and the theory of RBE. II. Evidence from track-segment experiments with protons and alpha particles. , 1966, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[9]  M Gambaccini,et al.  Dual-energy tissue cancellation in mammography with quasi-monochromatic x-rays. , 2002, Physics in medicine and biology.

[10]  M. Bauchinger,et al.  Chromosome aberration frequencies in human lymphocytes irradiated in a multi-layer array by protons with different LET. , 1997, International journal of radiation biology.

[11]  F Ianzini,et al.  RBE-LET relationships for cell inactivation and mutation induced by low energy protons in V79 cells: further results at the LNL facility. , 1998, International journal of radiation biology.

[12]  G. Kraft,et al.  Tumor therapy with heavy charged particles , 2000 .

[13]  G J Neary,et al.  Chromosome aberrations and the theory of RBE. 1. General considerations. , 1965, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[14]  A. Campa,et al.  A semi-empirical approach to the evaluation of the relative biological effectiveness of therapeutic proton beams: the methodological framework. , 1997, Radiation research.

[15]  J. Little,et al.  Radiobiological studies of a high‐energy modulated proton beam utilizing cultured mammalian cells , 1975 .

[16]  Harald Paganetti,et al.  Relative biological effectiveness (RBE) values for proton beam therapy. , 2002, International journal of radiation oncology, biology, physics.

[17]  E. Hall,et al.  The relative biological effectiveness of 160 MeV protons , 1978 .

[18]  D T Goodhead,et al.  Direct comparison between protons and alpha-particles of the same LET: I. Irradiation methods and inactivation of asynchronous V79, HeLa and C3H 10T1/2 cells. , 1992, International journal of radiation biology.

[19]  J. Fowler,et al.  Predicting realistic RBE values for clinically relevant radiotherapy schedules. , 1997, International journal of radiation biology.

[20]  Reinhard W. Schulte,et al.  Nuclear Data for Neutron and Proton Radiotherapy and for Radiation Protection , 2001 .

[21]  U Oelfke,et al.  Measurements of relative biological effectiveness of the 70 MeV proton beam at TRIUMF using Chinese hamster V79 cells and the high-precision cell sorter assay. , 1996, Radiation research.

[22]  S. C. Sharma,et al.  Inactivation of cells by heavy ion bombardment. , 1971, Radiation research.

[23]  M. Scholz,et al.  Calculation of Heavy Ion Inactivation Probabilities Based on Track Structure, X Ray Sensitivity and Target Size , 1994 .

[24]  M Zaider,et al.  The synergistic effects of different radiations. , 1980, Radiation research.

[25]  R. Hawkins.  A microdosimetric-kinetic theory of the dependence of the RBE for cell death on LET. , 1998, Medical physics.

[26]  A Ghebremedhin,et al.  Microdosimetry spectra of the Loma Linda proton beam and relative biological effectiveness comparisons. , 1997, Medical physics.

[27]  Skarsgard Ld,et al.  Radiobiology with heavy charged particles: a historical review. , 1998 .

[28]  P Chauvel,et al.  The depth-dependent radiation response of human melanoma cells exposed to 65 MeV protons. , 1994, The British journal of radiology.

[29]  Barendsen Gw.  RBE as a function of dose for effects on tissues and tumors assessed by the linear-quadratic model. , 2000 .

[30]  K M Prise,et al.  Inactivation of V79 cells by low-energy protons, deuterons and helium-3 ions. , 1996, International journal of radiation biology.

[31]  R. Hawkins.  A Microdosimetric-Kinetic Model for the Effect of Non-Poisson Distribution of Lethal Lesions on the Variation of RBE with LET , 2003, Radiation research.

[32]  L. Gerweck,et al.  Relative biological effectiveness of proton beams in clinical therapy. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[33]  A. Ruifrok,et al.  Proton RBE for early intestinal tolerance in mice after fractionated irradiation. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[34]  I. Spadinger,et al.  The relative biological effectiveness of 60Co gamma-rays, 55 kVp X-rays, 250 kVp X-rays, and 11 MeV electrons at low doses. , 1992, International journal of radiation biology.

[35]  P Lambin,et al.  Low-dose hypersensitivity: current status and possible mechanisms. , 2001, International journal of radiation oncology, biology, physics.

[36]  E Grusell,et al.  Relative biological effectiveness of intermediate energy protons. Comparisons with 60Co gamma-radiation using two cell lines. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[37]  M Goitein,et al.  Biophysical modelling of proton radiation effects based on amorphous track models , 2001, International journal of radiation biology.

[38]  A Brahme,et al.  Comparison of cell survival models for mixed LET radiation. , 1999, International journal of radiation biology.

[39]  B. Vojnovic,et al.  Low-Dose Hypersensitivity in Chinese Hamster V79 Cells Targeted with Counted Protons Using a Charged-Particle Microbeam , 2001, Radiation research.

[40]  L. Verhey,et al.  In vivo determinations of RBE in a high energy modulated proton beam using normal tissue reactions and fractionated dose schedules. , 1977, International journal of radiation oncology, biology, physics.

[41]  A M Kellerer,et al.  The relative biological effectiveness of 160 MeV protons--II. Biological data and their interpretation in terms of microdosimetry. , 1978, International journal of radiation oncology, biology, physics.

[42]  F Ianzini,et al.  Inactivation and mutation induction in V79 cells by low energy protons: re-evaluation of the results at the LNL facility. , 1993, International journal of radiation biology.

[43]  G K Lam,et al.  The survival response of a biological system to mixed radiations. , 1987, Radiation research.

[44]  M. Koizumi,et al.  Comparison of radiobiological effective depths in 65-MeV modulated proton beams. , 1997, British Journal of Cancer.

[45]  S. B. Field,et al.  The response of mouse skin to irradiation with neutrons from the 62 MV cyclotron at Clatterbridge, U.K. , 1988, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[46]  H. Rossi,et al.  The relative biological effectiveness of 160 MeV protons. I. Microdosimetry. , 1978, International journal of radiation oncology, biology, physics.

[47]  H. Paganetti.  Calculation of the spatial variation of relative biological effectiveness in a therapeutic proton field for eye treatment. , 1998, Physics in medicine and biology.

[48]  M. Scholz,et al.  Computation of cell survival in heavy ion beams for therapy , 1997, Radiation and environmental biophysics.

[49]  E. Sideris,et al.  Biological effectiveness of low energy protons. I. Survival of Chinese hamster cells. , 1986, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[50]  E. Blakely,et al.  Radiobiological characterization of the inactivating events produced in mammalian cells by helium and heavy ions. , 1977, International journal of radiation oncology, biology, physics.

[51]  R. Marchesini,et al.  Radiobiological studies on the 65 MeV therapeutic proton beam at Nice using human tumour cells. , 2000, International journal of radiation biology.

[52]  U. Oelfke,et al.  Three-dimensional LET calculations for treatment planning of proton therapy. , 2004, Zeitschrift fur medizinische Physik.

[53]  A. Kellerer,et al.  A Generalized Formulation of Dual Radiation Action1 , 1978 .

[54]  T Ogino,et al.  Relative biological effectiveness of the 235 MeV proton beams at the National Cancer Center Hospital East. , 2001, Journal of radiation research.